Abstract
Nine patients with osteosarcoma were treated by chemotherapy combined with caffeine and surgery. All primary tumors showed complete histological response to preoperative chemotherapy consisting of three intraarterial infusions of cisplatin and caffeine without/with doxorubicin and two systemic high-dose methotrexate combined with vincristine. Limb-salvage surgery was performed in eight patients with marginal procedure, which led to the preservation of good limb function. Below-knee amputation was done in one patient with calcaneal osteosarcoma. There has been neither local recurrence nor lung metastasis in seven patients with conventional osteosarcoma during a median follow-up period of 28 months. Lung metastases leading to death were observed in one patient with small-cell osteosarcoma despite complete destruction of the primary tumor by preoperative chemotherapy. Chemotherapy combined with caffeine administration deserves further extensive and large-scale study in osteosarcoma.
Key words: Osteosarcoma, Chemotherapy, Caffeine, Marginal excision
References
- Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, Brach Del Prever A, Mancini A, Ferruzzi A, Manfrini M, Campanacci M (1990) Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer 65:2539–2553 [DOI] [PubMed] [Google Scholar]
- Benjamin RS, Chawla SP, Carrasco C, Raymond AK, Fanning T, Wallace S, Ayala AG, Murray J (1988) Arterial infusion in the treatment of osteosarcoma. In: Ryan JR, Baker LO (eds) Recent concepts in sarcoma treatment. Kluwer Dordrecht, pp 269–274 [Google Scholar]
- Dougherty JB, Kelsen D, Kemeny N, Magill G, Botet J, Niedzwiecki D (1989) Advanced pancreatic cancer: a phase I–II trial of cisplatin, high-dose cytarabine, and caffeine. J Natl Cancer Inst 81:1735–1738 [DOI] [PubMed] [Google Scholar]
- Epelman S, Erstrada J, Jaffe N, Bianchi A (1990) Pediatric osteosarcoma. Successful retreatment of relapsed primary tumor and soft tissue recurrence with intraarterialcis-diamminedichloroplatin-II. Cancer 66:801–805 [DOI] [PubMed] [Google Scholar]
- Jaffe N, Knapp J, Chuang VP, Wallace S, Ayala A, Murray J, Cangir A, Wang A, Benjamin RS (1983) Osteosarcoma: intra-arterial treatment of the primary tumor withcis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic and pharmacologic studies. Cancer 51:402–407 [DOI] [PubMed] [Google Scholar]
- Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230 [DOI] [PubMed] [Google Scholar]
- Stine KC, Hockenberry MJ, Harrelson J, Miner D, Falletta JM (1989) Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma. Cancer 63:848–853 [DOI] [PubMed] [Google Scholar]
- Tateishi A, Miki H, Takeyama S, Ishii S, Yamawaki S, Yagi T, Kakizaki H, Chigira M, Takada N, Endo F, Kawano H, Osaka S, Higaki S, Hamada Y, Takeuchi S, Tomita K, Matsui H, Sinjo K, Daisaku H, Inoue O (1989) The effects of preoperative cisplatinum (CDDP) therapy for the purpose of limb salvage of osteosarcoma evaluated by multifactor evaluation method. In: Yamamuro T (ed) New developments for limb salvage in musculoskeletal tumors. Springer, Tokyo Berlin Heidelberg New York, pp 189–192 [Google Scholar]
- Tomita K, Tsuchiya H (1989a) Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 80:83–88 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomita K, Tsuchiya H (1989b) Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma. Clin Ther 11:43–52 [PubMed] [Google Scholar]
- Tomita K, Tsuchiya H (1989c) Intermediate results and functional evaluation of limb-salvage surgery for osteosarcoma: an intergroup study in Japan. J Surg Oncol 41:71–76 [DOI] [PubMed] [Google Scholar]
- Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erttmann R, Gobel U, Havers W, Henze G, Hinderfeld L, Hocker P, Jobke A, Jurgens H, Kabisch H, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wust G, Landbeck G (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol 2:617–6246202851 [Google Scholar]
- Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfurst C, Berger J, Ritter J, Jurgens H, Gerein V, Graf N, Russe W, Gruemayer ER, Ertelt W, Kotz R, Preusser P, Prindull G, Brandeis W, Landbeck G (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337 [DOI] [PubMed] [Google Scholar]
- Winkler K, Bieleck S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw G, Jurgens H, Ritter J, Kusnierz-Glaz G, Erttmann R, Gadicke G, Graf N, Landenstein R, Leyvraz S, Mertens R, Weinel P (1990) Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 66:1703–1710 [DOI] [PubMed] [Google Scholar]